PubRank

Erdenechimeg Shagdarsuren

Author PubWeight™ 36.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009 4.73
2 Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2007 2.85
3 CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2008 2.52
4 Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 2002 2.50
5 Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 2008 2.42
6 Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2006 1.99
7 Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Hypertension 2005 1.89
8 Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension 2005 1.74
9 Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 2007 1.49
10 Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice. J Hypertens 2004 1.39
11 Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 2004 1.32
12 Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation 2005 1.23
13 A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol 2004 1.15
14 Angiotensin II-induced sudden arrhythmic death and electrical remodeling. Am J Physiol Heart Circ Physiol 2007 1.13
15 Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 2007 1.04
16 P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage. Hypertension 2002 0.97
17 p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension 2007 0.97
18 Aldosterone, mineralocorticoid receptors, and vascular inflammation. Curr Opin Nephrol Hypertens 2007 0.92
19 Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiol Genomics 2004 0.88
20 Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes. J Renin Angiotensin Aldosterone Syst 2007 0.86
21 Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation 2008 0.85
22 Hematopoietic interferon regulatory factor 8-deficiency accelerates atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012 0.84
23 Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage. Kidney Int 2005 0.82
24 Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions. Thromb Haemost 2013 0.81
25 Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation. Cardiovasc Res 2007 0.75